(AP Photo/Jessica Hill, File)

Several leading insurers have agreed to start paying for the popular weight loss drug Wegovy for Medicare recipients with certain heart conditions. However, coverage will not include use for weight loss alone.

CVS Health's Aetna, Elevance Health and Kaiser Permanente will pay for Wegovy to reduce heart attack risk in patients with cardiovascular conditions who meet certain body weight criteria and are enrolled in Medicare drug coverage. Elevance, which operates many Blue Cross and Blue Shield health plans, said it also will extend coverage to patients insured by a commercial plan.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Employee Participation
Employee-Paid
Employer-Paid